Rhodesiense trypanosomiasis, also known as African sleeping sickness, is caused by the protozoan parasite Trypanosoma brucei rhodesiense, transmitted through the bite of infected tsetse flies. This condition is clinically significant due to its potential for severe neurological complications and high mortality if untreated. The ICD-10 Code B56.1 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this infectious disease.
ICD-10 Code B56.1 specifically represents Rhodesiense trypanosomiasis, a form of sleeping sickness caused by the Trypanosoma brucei rhodesiense parasite. This code should be used in clinical documentation and billing when diagnosing patients with this condition, particularly when symptoms such as fever, headache, and neurological disturbances are present, indicating the need for appropriate treatment and monitoring.
Rhodesiense trypanosomiasis is an infectious disease caused by the Trypanosoma brucei rhodesiense parasite, primarily transmitted through tsetse fly bites. The disease progresses through stages, initially presenting with fever and malaise, followed by neurological symptoms as it advances. Prompt medical attention is crucial to prevent severe complications and mortality.
In SOAP notes, ICD-10 Code B56.1 is utilized to document the diagnosis of Rhodesiense trypanosomiasis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
ICD-10 Code B56.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Rhodesiense trypanosomiasis. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Rhodesiense trypanosomiasis requires urgent medical intervention, often necessitating hospitalization for effective management. Treatment typically involves specific antiparasitic medications.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code B56.1 is crucial for billing purposes in hospital, emergency room, or infectious disease care settings.
CPT Code | Description |
---|---|
99221 | Initial hospital care, typically for a new patient. |
96365 | Intravenous infusion, for therapeutic, prophylactic, or diagnostic purposes. |
36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code B56.1 for Rhodesiense trypanosomiasis
What are the common symptoms of Rhodesiense trypanosomiasis?
Common symptoms include fever, headaches, fatigue, and swollen lymph nodes. As the disease progresses, neurological symptoms such as confusion and sleep disturbances may occur.
How is Rhodesiense trypanosomiasis diagnosed?
Diagnosis is typically made through clinical evaluation, patient history, and laboratory tests that identify the Trypanosoma brucei rhodesiense parasite in blood or cerebrospinal fluid.
What is the treatment for Rhodesiense trypanosomiasis?
Treatment involves the administration of antiparasitic medications such as Suramin for early-stage disease or Eflornithine for late-stage disease, along with supportive care.
Is Rhodesiense trypanosomiasis contagious?
No, Rhodesiense trypanosomiasis is not contagious and is transmitted through the bite of infected tsetse flies, not through person-to-person contact.
Clinical Notes
SOAP notes
DAP notes
AI medical notes